Big money tends to bring out the big guns.

That was evident at a lengthy hearing on Nov. 22 before U.S. District Judge Thomas F. Hogan, of Washington, D.C., who is overseeing the $1.17 billion settlement of a massive class action that accuses the world’s leading vitamin makers of a global price-fixing conspiracy. High-priced legal talent from firms such as Washington, D.C.’s Williams & Connolly and Howrey & Simon packed his courtroom to attack a provision to allow at least 96 companies to opt out of the settlement to recover greater damages.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]